ALTANA PHARMA AG
85Patents
4Active
85Granted
36Portfolio score
Filing activity: Nov 13, 1998 → Mar 30, 2010 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6476025B1 | Phenylphennanthridines with PDE-IV inhibiting activity | Chemistry; Metallurgy | 45 | Expired |
| US6569453B2 | Administration form comprising an acid-labile active compound | Human Necessities | 28 | Expired |
| US7147869B2 | Rapidly disintegrating tablet comprising an acid-labile active ingredient | Human Necessities | 24 | Expired |
| US7175854B2 | Pharmaceutical preparation comprising an active dispersed on a matrix | Human Necessities | 17 | Expired |
| US6988619B2 | Medicinal product package for eradication therapy | Performing Operations; Transporting | 16 | Expired |
| US6534518B1 | Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity | Human Necessities | 15 | Expired |
| US7034178B2 | Process for the production of 3-phenylisoserine | Chemistry; Metallurgy | 14 | Expired |
| US6544993B1 | Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors | Chemistry; Metallurgy | 13 | Expired |
| US6479505B1 | 6-arylphenanthridines with PDE-IV inhibiting activity | Chemistry; Metallurgy | 12 | Expired |
| US6534519B1 | Phenanthridine-N-oxides with PDE-IV inhibiting activity | Human Necessities | 12 | Expired |
| US6936622B2 | 6-phenylbenzonaphthyridines | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6858223B2 | Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) | Human Necessities | 12 | Expired |
| US6916825B2 | Alkylated imidazopyridine derivatives | Chemistry; Metallurgy | 12 | Expired |
| US6884802B2 | 6-heteroarylphenanthridines | Chemistry; Metallurgy | 12 | Expired |
| US6538005B2 | Phenanthridine-N-oxides with PDE-IV inhibiting activity | Human Necessities | 12 | Expired |
| US7056936B2 | Synergistic combination | Human Necessities | 10 | Expired |
| US7186710B2 | Phthalazinones | Chemistry; Metallurgy | 10 | Expired |
| US6818651B2 | (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors | Chemistry; Metallurgy | 10 | Expired |
| US6953853B2 | Phthalazinone-piperidino-derivatives as PDE4 inhibitors | Chemistry; Metallurgy | 9 | Expired |
| US7202055B2 | Process for the production of proteins and the production of arrays of proteins | Chemistry; Metallurgy | 9 | Expired |
| US7053176B1 | Combination of C1-INH and lung surfactant for the treatment of respiratory disorders | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6503923B1 | Haloalkoxy imidazonaphthyridines | Human Necessities | 8 | Expired |
| US6624181B1 | Synergistic combination | Human Necessities | 8 | Expired |
| US6767901B1 | Ciclesonide contained pharmaceutical composition for application to mucosa | Human Necessities | 7 | Expired |
| US6780881B2 | Freeze-dried pantoprazole preparation and pantoprazole injection | Human Necessities | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.